EGR2 maintains neuropathic pain by promoting microglial phagocytosis.
10.11817/j.issn.1672-7347.2025.240270
- Author:
Caiyun XI
1
,
2
;
Jianxi ZHANG
1
,
3
;
Zhifeng HUANG
1
;
Liqiong HE
1
;
Kailu ZOU
1
;
Xiaoping XU
1
;
Qulian GUO
1
;
Bei SUN
1
,
4
;
Changsheng HUANG
1
,
5
Author Information
1. Department of Anesthesiology, Xiangya Hospital, Central South University, Changsha
2. 218111145@csu.edu.cn.
3. 218112366@csu.edu.cn.
4. sunbei2017@sina.com.
5. changsheng.huang@csu.edu.cn.
- Publication Type:Journal Article
- Keywords:
early growth response factor 2;
microglia;
neuropathic pain;
phagocytosis;
spinal dorsal horn
- MeSH:
Animals;
Microglia/metabolism*;
Phagocytosis/physiology*;
Rats, Sprague-Dawley;
Neuralgia/physiopathology*;
Early Growth Response Protein 2/metabolism*;
Male;
Rats;
Spinal Cord/metabolism*;
Sciatic Nerve/injuries*
- From:
Journal of Central South University(Medical Sciences)
2025;50(4):586-601
- CountryChina
- Language:English
-
Abstract:
OBJECTIVES:Neuropathic pain (NP) is one of the most common forms of chronic pain, yet current treatment options are limited in effectiveness. Peripheral nerve injury activates spinal microglia, altering their inflammatory response and phagocytic functions, which contributes to the progression of NP. Most current research on NP focuses on microglial inflammation, with relatively little attention to their phagocytic function. Early growth response factor 2 (EGR2) has been shown to regulate microglial phagocytosis, but its specific role in NP remains unclear. This study aims to investigate how EGR2 modulates microglial phagocytosis and its involvement in NP, with the goal of identifying potential therapeutic targets.
METHODS:Adult male Sprague-Dawley (SD) rats were used to establish a chronic constriction injury (CCI) model of the sciatic nerve. Pain behaviors were assessed on days 1, 3, 7, 10, and 14 post-surgery to confirm successful model induction. The temporal and spatial expression of EGR2 in the spinal cord was examined using real-time quantitative PCR (RT-qPCR), Western blotting, and immunofluorescence staining. Adeno-associated virus (AAV) was used to overexpress EGR2 in the spinal cord, and behavioral assessments were performed to evaluate the effects of EGR2 modulation of NP. CCI and lipopolysaccharide (LPS) models were established in animals and microglial cell lines, respectively, and changes in phagocytic activity were measured using RT-qPCR and fluorescent latex bead uptake assays. After confirming the involvement of microglial phagocytosis in NP, AAV was used to overexpress EGR2 in both in vivo and in vitro models, and phagocytic activity was further evaluated. Finally, eukaryotic transcriptome sequencing was conducted to screen differentially expressed mRNAs, followed by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses to identify potential downstream effectors of EGR2.
RESULTS:The CCI model successfully induced NP. Following CCI, EGR2 expression in the spinal cord was upregulated in parallel with NP development. Overexpression of EGR2 via spinal AAV injection enhanced microglial phagocytic activity and increased pain hypersensitivity in rats. Both animal and cellular models showed that CCI or LPS stimulation enhanced microglial phagocytosis, which was further amplified by EGR2 overexpression. Transcriptomic analysis of spinal cord tissues from CCI rats overexpressing EGR2 revealed upregulation of numerous genes associated with microglial phagocytosis and pain regulation. Among them, Lag3 emerged as a potential downstream target of EGR2.
CONCLUSIONS:EGR2 contributes to the maintenance of NP by enhancing microglial phagocytosis in the spinal dorsal horn.
